Categories
Videos

Proof that puts an end to the Sars-CoV-2 Narrative – Professor Sucharit Bhakdi, Oracle Films

Some good news and some troubling news, from Professor Sucharit Bhakdi, M.D.

Oracle Films recently produced an interview with Professor Sucharit Bhakdi in collaboration with Oval Media in Germany, for an upcoming documentary.

As an aside to the interview, Dr. Bhakdi emphasised the urgent need to share the following information that has emerged from new scientific literature.

PLEASE take the time to process this presentation. Dr. Bhakdi explains clearly, based on new scientific evidence, why he believes:

* Your immune system is your best defence against SARS-CoV-2, and indeed all coronaviruses. If you have been infected, even if you experienced no symptoms at all, you are immune to all variants.
* We have already reached herd immunity.
* There is no scientific reason to vaccinate against SARS-CoV-2. There is simply no benefit and the rollout must be stopped.

Scientific literature references for Dr. Bhakdi’s presentation:

Update: On 17 July 2021, Dr. Geert Vanden Bossche posted a response to Dr. Bhakdi’s conclusions. Both agree that mass vaccination should halt but differ on the dangers of variants and whether herd immunity has been reached.

Categories
News

Common colds could prime the immune system to fight off Covid – The Telegraph

Common colds may prime the immune system against Covid, scientists believe, after finding that some people never develop an infection despite repeated exposure to the virus.

Researchers at University College London (UCL) have discovered that some people have natural protection against Covid and seem to fight off an infection using pre-existing memory T-cells.

https://www.telegraph.co.uk/news/2021/07/02/common-colds-could-prime-immune-system-fight-covid/

Categories
Publications

SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity – Science Direct

We report broad serological profiles within the cohort, detecting antibody binding to other human coronaviruses. 202(>99%) participants had SARS-CoV-2 specific antibodies, with SARS-CoV-2 neutralization and spike-ACE2 receptor interaction blocking observed in 193(95%) individuals. A significant positive correlation (r=0.7804) between spike-ACE2 blocking antibody titers and neutralization potency was observed. Further, SARS-CoV-2 specific CD8+ T-cell responses were clear and quantifiable in 95 of 106(90%) HLA-A2+ individuals.

https://www.sciencedirect.com/science/article/pii/S2352396421002036

Categories
Publications

Human IgG and IgA responses to COVID-19 mRNA vaccines – PLOS ONE

SARS-CoV-2 spike antigen-specific IgG and IgA elicited by infection mediate viral neutralization and are likely an important component of natural immunity, however, limited information exists on vaccine induced responses. We measured COVID-19 mRNA vaccine induced IgG and IgA in serum serially, up to 145 days post vaccination in 4 subjects. Spike antigen-specific IgG levels rose exponentially and plateaued 21 days after the initial vaccine dose. After the second vaccine dose IgG levels increased further, reaching a maximum approximately 7–10 days later, and remained elevated (average of 58% peak levels) during the additional >100 day follow up period. COVID-19 mRNA vaccination elicited spike antigen-specific IgA with similar kinetics of induction and time to peak levels, but more rapid decline in serum levels following both the 1st and 2nd vaccine doses (<18% peak levels within 100 days of the 2nd shot). The data demonstrate COVID-19 mRNA vaccines effectively induce spike antigen specific IgG and IgA and highlight marked differences in their persistence in serum.

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0249499

Categories
Publications

Manipulative magnetic nanomedicine: the future of COVID-19 pandemic/endemic therapy – Taylor & Francis Online

Published 14 Dec 2020

Nanobiotechnology is emerging very promising to investigate novel methodologies for managing COVID-19 pandemic/endemic successfully. In this direction, experts have explored the opto-electro-magnetic nanosystem to detect the SARS-CoV-2 virus using a biosensing approach. Such optical, electrical, or magnetic biosensors function based on geno-sensing and immune-sensing has detected the SARS-CoV-2 virus selectively at a very low level. These efficient-miniaturized biosensors can be operated using a smartphone and promoted for clinical application for early-stage diagnostics of COVID-19 infection. The successful integration of these SARS-CoV-2 virus sensors with AI and IoMT enables virus detection at point-of-location and sharing of bioinformatics with the medical center at the same time for timely therapeutics decision. This approach is also useful for tracking tasks and managing COVID-19 infection according to patient infection profiling. To avoid human-to-human SARS-CoV-2 virus transmission, experts have developed stimuli-responsive nanotechnology enable which can not only trap aerosol of virus size but can eradicate viruses on applying external stimulation for example nanoenable photo-sensitive virus degradation. Various types of clothes containing nanoparticles have demonstrated SARS-CoV-2 virus trapping and eradication successfully [2,9]. However, significant attention is required to increase the production and distribution of these masks for public use.

https://www.tandfonline.com/doi/full/10.1080/17425247.2021.1860938

Categories
Publications

Pfizer-BioNTech vaccine recipients have lower antibody levels targeting the Delta variant first discovered in India – The Francis Crick Institute

Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating variants in the UK, according to new laboratory data from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre, published today (Thursday) as a Research letter in The Lancet.

The results also show that levels of these antibodies are lower with increasing age and that levels decline over time, providing additional evidence in support of plans to deliver a vaccination boost to vulnerable people in the Autumn. 

https://www.crick.ac.uk/news/2021-06-03_pfizer-biontech-vaccine-recipients-have-lower-antibody-levels-targeting-the-delta-variant-first-discovered-in-india

Categories
Publications

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination – The Lancet

In the case of single-dose recipients, our data show that NAbTs are significantly lower against B.1.617.2 and B.1.351 VOCs relative to B.1.1.7, implying that although a single dose might still afford considerably more protection than no vaccination, single-dose recipients are likely to be less protected against these SARS-CoV-2 variants. These data therefore suggest that the benefits of delaying the second dose, in terms of wider population coverage and increased individual NAbTs after the second dose,7 must now be weighed against decreased efficacy in the short-term, in the context of the spread of B.1.617.2. Worldwide, our data highlight the ongoing need to increase vaccine supply to allow all countries to extend second-dose protection as quickly as possible.

In the longer term, we note that both increased age and time since the second dose of BNT162b2 significantly correlate with decreased NAb activity against B.1.617.2 and B.1.351—both of which are also characteristic of the population in the UK at highest risk of severe COVID-19 (ie, older and vaccinated earlier), independent of other existing factors such as compromised immune status or comorbidity, or geographic-specific responses to vaccination.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01290-3/fulltext

Categories
Publications

Had COVID? You’ll probably make antibodies for a lifetime – Nature

People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades, although viral variants could dampen some of the protection they offer.

Many people who have been infected with SARS-CoV-2 will probably make antibodies against the virus for most of their lives. So suggest researchers who have identified long-lived antibody-producing cells in the bone marrow of people who have recovered from COVID-19.

https://www.nature.com/articles/d41586-021-01442-9

Categories
News

How the vaccine can make Covid worse – Conservative Woman

EVIDENCE is growing that Covid-19 vaccines may worsen the disease in some recipients. The danger arises when a vaccinated person meets the actual virus. Antibodies developed as a result of the jab can end up enhancing disease rather than protecting against infection.

Previous warnings about this potentially lethal effect, known as antibody-dependent enhancement (ADE), have been downplayed or dismissed as theoretical by the manufacturers. The phenomenon has been seen with vaccines against other viruses but is considered very rare.

After reviewing published evidence concerning the effect, however, two US experts [1] have concluded it is ‘non-theoretical and compelling’. Receiving the vaccine could convert a subject from someone who experiences mild disease ‘to someone who experiences severe disease, lasting morbidity or even death’. 

https://www.conservativewoman.co.uk/how-the-vaccine-can-make-covid-worse/

Categories
Videos

Professor Dolores Cahill says that mRNA vaccines enhances the illness and the disease – Asia Pacific Today

Citizens subjected to punitive restrictions on their liberties and movement for more than 12 months, are now being forced into mass, and what will soon be, mandatory vaccination programs to gain back their freedoms. Political leaders continue use the vacuous and dishonest slogan of “following the science” that many still believe, but are they leading us into another form of hell?

The Covid-19 vaccines are new vaccines and only provisionally approved. They are still in the trial phase which ends at earliest in 2023. Brilliant they may well be, and enormously enriching for their investors, but are our Government’s providing the facts for informed choice in vaccination? Are there other risks to their rushed vaccine rollouts, including to front line medical and essential service workers? And why are so many eminent scientists and influential community leaders in our countries being silenced by social and mainstream media?

The Victorian Government recently commissioned a paper entitled Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. We are not hopeful but will attempt to discuss the paper with one of its authors in another episode.

In the meantime, to talk about mRNA vaccines and Antibody Dependent Enhancement is Professor Dolores Cahill, a renown expert in immunology and the study of immune systems.

Dr. Cahill is a Professor of University College Dublin and was Group Leader of the Max-Planck-Institute in Berlin, Germany from 1995 to 2003. She is an Inventor, Founder and Shareholder of companies and has international Patents with applications for improving the early diagnosis of diseases such as auto immune diseases & cancer.

Dr. Cahill has been an Expert in the EU for some 15 years in Future & Emerging technologies. Professor Cahill’s latest business ventures include the World Freedom Alliance, a worldwide platform of organisations offering access to justice, true dialogue for health science and politics, holding worldwide officials to account under the law. The World Freedom Alliance offers transparent evidence-based solutions and encourages robust debate with media, scientists and governments to ensure fundamental freedoms for people of the world.

Categories
News

How did Sage get it so wrong? – The Spectator

Professor Neil Ferguson struck an unusually optimistic tone this week. With just one Covid death reported on Monday, and infection levels at an eight-month low in the UK, the architect of the original lockdown said: ‘The data is very encouraging and very much in line with what we expected.’ The first half of that statement is certainly true; the second half much less so.

https://www.spectator.co.uk/article/How-did-Sage-get-it-so-wrong

Categories
Opinion Videos

Covid is the cure worse than the disease? Dr John Lee, Unlocked

Unlocked Exclusive — in a hard-hitting interview, retired NHS pathologist Dr John Lee discusses the government’s response to the pandemic, analyses why proven scientific procedures were abandoned, makes the case for ending Lockdown now, and asks the question most doctors are unable to discuss in public. Covid-19: is the cure worse than the disease?

Backup mirrors:

https://www.facebook.com/unlockedunitedkingdom/videos/506787697359395/

Categories
Opinion

We’ll Have Herd Immunity by April – Wall Street Journal

Amid the dire Covid warnings, one crucial fact has been largely ignored: Cases are down 77% over the past six weeks. If a medication slashed cases by 77%, we’d call it a miracle pill. Why is the number of cases plummeting much faster than experts predicted?

In large part because natural immunity from prior infection is far more common than can be measured by testing. Testing has been capturing only from 10% to 25% of infections, depending on when during the pandemic someone got the virus. Applying a time-weighted case capture average of 1 in 6.5 to the cumulative 28 million confirmed cases would mean about 55% of Americans have natural immunity.

…explained only by natural immunity. Behavior didn’t suddenly improve over the holidays; Americans traveled more over Christmas than they had since March. Vaccines also don’t explain the steep decline in January. Vaccination rates were low and they take weeks to kick in.

https://www.wsj.com/articles/well-have-herd-immunity-by-april-11613669731

Categories
News

Why did COVID fail to take off in India and has now collapsed? Mystery plunge in coronavirus baffles experts – Daily Mail

Scientists are trying to work out why coronavirus cases in India are falling when at one point it looked like the country might overtake the US as the worst-hit nation.

In September the country was reporting some 100,00 new cases per day, but that went into decline in October and is now sitting at around 10,000 per day – leaving experts struggling to explain why.

While the Indian government has been keen to put the apparent success down to its mask-wearing and social distancing laws, few believe these measures alone are responsible for the dip.

Instead, experts believe it may be down to the fact that India’s largest cities have reached herd immunity, meaning the virus has moved to rural areas where it spreads slower and where cases and deaths are far less likely to be tested and logged. 

https://www.accuweather.com/en/gb/kensington/w8-7/minute-weather-forecast/323272

Categories
Publications

Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based “CONSTANCES” cohort – European Journal of Epidemiology

Using serum samples routinely collected in 9144 adults from a French general population-based cohort, we identified 353 participants with a positive anti-SARS-CoV-2 IgG test, among whom 13 were sampled between November 2019 and January 2020 and were confirmed by neutralizing antibodies testing. Investigations in 11 of these participants revealed experience of symptoms possibly related to a SARS-CoV-2 infection or situations at risk of potential SARS-CoV-2 exposure. This suggests early circulation of SARS-CoV-2 in Europe.

https://link.springer.com/article/10.1007/s10654-020-00716-2

Categories
Opinion Videos

Ivor Cummins on The James Delingpole Channel

Ivor Cummins aka the Fat Emperor – gives James the lowdown on why you can’t trust anything our governments tell us about Covid-19. If you want the facts on Coronavirus – how deadly is it? do lockdowns and masks work? how does it compare with previous pandemics? – you’ve come to the right place

Please support the Delingpod:

Mirror archives are available below if this video is removed from YouTube.

Categories
Publications

Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic – JAMA

Conclusions and Relevance  In this cohort study, there was no evidence of placental infection or definitive vertical transmission of SARS-CoV-2. Transplacental transfer of anti-SARS-CoV-2 antibodies was inefficient. Lack of viremia and reduced coexpression and colocalization of placental angiotensin-converting enzyme 2 and transmembrane serine protease 2 may serve as protective mechanisms against vertical transmission.

https://web.archive.org/web/20201222162005/https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2774428

Categories
Publications

How kids’ immune systems can evade COVID – Nature

Young children account for only a small percentage of COVID-19 infections — a trend that has puzzled scientists. Now, a growing body of evidence suggests why: kids’ immune systems seem better equipped to eliminate SARS-CoV-2 than are adults’.

“Children are very much adapted to respond — and very well equipped to respond — to new viruses,” says Donna Farber, an immunologist at Columbia University in New York City. Even when they are infected with SARS-CoV-2, children are most likely to experience mild or asymptomatic illness.

Another clue that children’s response to the virus differs from that of adults is that some children develop COVID-19 symptoms and antibodies specific to SARS-CoV-2 but never test positive for the virus on a standard RT-PCR test. In one study, three children under ten from the same family developed SARS-CoV-2 antibodies — and two of them even experienced mild symptoms — but none tested positive on RT-PCR, despite being tested 11 times over 28 days while in close contact with their parents, who had tested positive.

https://web.archive.org/web/20201211205033/https://www.nature.com/articles/d41586-020-03496-7

Categories
Publications

Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease – National Center for Biotechnology Information

COVID-19 vaccines designed to elicit neutralising antibodies may sensitise vaccine recipients to more severe disease than if they were not vaccinated. Vaccines for SARS, MERS and RSV have never been approved, and the data generated in the development and testing of these vaccines suggest a serious mechanistic concern: that vaccines designed empirically using the traditional approach (consisting of the unmodified or minimally modified coronavirus viral spike to elicit neutralising antibodies), be they composed of protein, viral vector, DNA or RNA and irrespective of delivery method, may worsen COVID-19 disease via antibody-dependent enhancement (ADE). This risk is sufficiently obscured in clinical trial protocols and consent forms for ongoing COVID-19 vaccine trials that adequate patient comprehension of this risk is unlikely to occur, obviating truly informed consent by subjects in these trials.

Categories
Videos

Dr Mike Yeadon on the UK government’s mismanagement of COVID-19 on – Unlocked

YouTube has removed interview so we have archived the video in the above location. It is currently available on Unlocked Facebook page:

https://www.facebook.com/unlockedunitedkingdom/videos/vb.112364983833705/409747283542470/